Fernando de Alvaro
Overview
Explore the profile of Fernando de Alvaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gorostidi M, Sanchez-Martinez M, Ruilope L, Graciani A, de la Cruz J, Santamaria R, et al.
Nefrologia (Engl Ed)
. 2018 Jun;
38(6):606-615.
PMID: 29914761
Background: Chronic kidney disease (CKD) is a public health problem worldwide. We aimed to estimate the CKD prevalence in Spain and to examine the impact of the accumulation of cardiovascular...
2.
Aragoncillo I, Abad S, Caldes S, Amezquita Y, Vega A, Cirugeda A, et al.
J Vasc Access
. 2017 Apr;
18(4):352-358.
PMID: 28430315
Purpose: Stenosis is the main cause of arteriovenous fistula (AVF) failure. It is still unclear whether surveillance based on vascular access blood flow (QA) enhances AVF function and longevity. Methods:...
3.
Quiroga B, de Lorenzo A, Vega C, de Alvaro F
Am J Case Rep
. 2016 Dec;
17:950-956.
PMID: 27974740
BACKGROUND Recent advances in the treatment of atypical hemolytic-uremic syndrome (aHUS) have resulted to better long-term survival rates for patients with this life-threatening disease. However, many questions remain such as...
4.
Aragoncillo I, Amezquita Y, Caldes S, Abad S, Vega A, Cirugeda A, et al.
J Vasc Access
. 2015 Sep;
17(1):13-9.
PMID: 26391583
Purpose: The usefulness of access blood flow (QA) measurement is an ongoing controversy. Although all vascular access (VA) clinical guidelines recommend monitoring and surveillance protocols to prevent VA thrombosis, randomized...
5.
Martinez-Castelao A, Navarro-Gonzalez J, Gorriz J, de Alvaro F
J Clin Med
. 2015 Aug;
4(6):1207-16.
PMID: 26239554
Diabetes Mellitus (DM) is a growing worldwide epidemic. It was estimated that more than 366 million people would be affected. DM has spread its presence over the world due to...
6.
Portoles J, Gorriz J, Rubio E, de Alvaro F, Garcia F, Alvarez-Chivas V, et al.
BMC Nephrol
. 2013 Jan;
14:2.
PMID: 23295149
Background: Anemia is a common condition in CKD that has been identified as a cardiovascular (CV) risk factor in end-stage renal disease, constituting a predictor of low survival. The aim...
7.
Martinez-Castelao A, Gorriz J, Sola E, Morillas C, Jover A, Coronel F, et al.
Nefrologia
. 2012 Jul;
32(4):419-26.
PMID: 22806275
No abstract available.
8.
Martinez-Castelao A, Gorriz J, Portoles J, de Alvaro F, Cases A, Luno J, et al.
BMC Nephrol
. 2011 Oct;
12:53.
PMID: 21970625
Background: To obtain information on cardiovascular morbidity, hypertension control, anemia and mineral metabolism based on the analysis of the baseline characteristics of a large cohort of Spanish patients enrolled in...
9.
Portoles J, Martinez Castelao A, Gorriz J, Tato A, de Alvaro F
Ren Fail
. 2009 Dec;
31(10):869-75.
PMID: 20030520
Background/aim: There is little information on the development of anemia in the early stages of chronic kidney disease. The aim of this study was to analyze the onset of renal...
10.
Lobos Bejarano J, Royo-Bordonada M, Brotons C, Alvarez-Sala L, Armario P, Maiques A, et al.
Aten Primaria
. 2009 Jul;
41(8):463.e1-463.e24.
PMID: 19608301
The present CEIPC Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2008. This guide recommends the SCORE model for risk evaluation. The aim is to...